إعلان
إعلان

TOVX

TOVX logo

Theriva Biologics, Inc.

0.21
USD
برعاية
-0.01
-3.37%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

0.22

0.00
+1.89%

تقارير أرباح TOVX

النسبة الإيجابية المفاجئة

TOVX تفوق 33 من 39 آخر التقديرات.

85%

التقرير التالي

بيانات التقرير القادم
٠٤ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.44
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-2.22%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-86.63%

Theriva Biologics, Inc. earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, TOVX reported earnings of -0.45 USD per share (EPS) for Q3 25, beating the estimate of -0.77 USD, resulting in a 41.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +8.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 المحللين forecast an EPS of -0.44 USD, with revenue projected to reach -- USD, implying an نقصان of -2.22% EPS, and زيادة of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
٢٦ ديسمبر ٢٠٢٥ إلى ربع سنوي4 25
تقدير
-$0.49
الفعلي
-
مفاجئة
-
الأسئلة الشائعة
For Q3 2025, Theriva Biologics, Inc. reported EPS of -$0.45, beating estimates by 41.57%, and revenue of $0.00, 0% as expectations.
The stock price moved up 8.05%, changed from $0.28 before the earnings release to $0.30 the day after.
The next earning report is scheduled for ٠٤ مارس ٢٠٢٦.
Based on 4 المحللين, Theriva Biologics, Inc. is expected to report EPS of -$0.44 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان